Cargando…
ZEB1 in Pancreatic Cancer
Pancreatic cancer is one of the most malignant human neoplasias. On the molecular level, epithelial-mesenchymal transition (EMT) has been demonstrated to contribute to the malignant phenotype of pancreatic cancer cells. ZEB1 is a transcriptional repressor that has been identified as an inducer of EM...
Autores principales: | Wellner, Ulrich, Brabletz, Thomas, Keck, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837326/ https://www.ncbi.nlm.nih.gov/pubmed/24281177 http://dx.doi.org/10.3390/cancers2031617 |
Ejemplares similares
-
ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
por: Meidhof, Simone, et al.
Publicado: (2015) -
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
por: Burk, Ulrike, et al.
Publicado: (2008) -
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
por: Lehmann, Waltraut, et al.
Publicado: (2016) -
The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
por: Mock, Kerstin, et al.
Publicado: (2015) -
The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses
por: Ungefroren, Hendrik, et al.
Publicado: (2022)